title: Intraocular pressure rise in the course of peginterferon alpha-2a, ribavirin, and boceprevir therapy for hepatitis C.
authors.affiliation: Faculty of Medicine, University of Toronto, Toronto.
authors.forename: Faizah
authors.initials: F
authors.lastname: Ilyas
authors.affiliation: Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto.
authors.forename: Harmanjit
authors.initials: H
authors.lastname: Singh
authors.affiliation: Trillium Health Partners, Mississauga, Ontario.
authors.forename: Navin
authors.initials: N
authors.lastname: Anand
authors.affiliation: Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto; Trillium Health Partners, Mississauga, Ontario; Credit Valley EyeCare, Mississauga, Ontario, Canada. Electronic address: ikeahmed@mac.com.
authors.forename: Iqbal Ike K
authors.initials: II
authors.lastname: Ahmed
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005902:Glaucoma, Open-Angle / Q000150:complications*; D006068:Gonioscopy; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects; D007429:Intraocular Pressure / Q000187:drug effects*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects; D011392:Proline / Q000009:adverse effects / Q000031:analogs & derivatives; D011994:Recombinant Proteins / Q000009:adverse effects; D012254:Ribavirin / Q000009:adverse effects; D014065:Tonometry, Ocular; D019562:Viral Load; D014794:Visual Fields
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline; C100416:peginterferon alfa-2a